HR 2700
106th Congress
House
International Affairs
Access to health care
Africa (Sub-Saharan)
American economic assistance
Antitrust law
Appropriations
Clinical trials
Commerce
Competition
Drug industry
Drugs
Economics and Public Finance
Federal aid to medical research
Federal receipts and expenditures
Foreign Trade and International Finance
Health
Human experimentation in medicine
Intellectual property
Medical ethics
Medical research
HELP for Africa Act
Introduced: August 4, 1999
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 1, 1999
Referred to the Subcommittee on Africa.
Sep 1, 1999
Referred to the Subcommittee on International Economic Policy and Trade.
Aug 4, 1999
Referred to the House Committee on International Relations.
Aug 4, 1999
Introduced in House
Plain-English summary
Highly Essential Lifesaving Pharmaceuticals for Africa Act (HELP for Africa Act) - Prohibits the use of funds appropriated to any Federal department or agency: (1) for the conduct of clinical research in a sub-Saharan African country unless specified conditions are met; or (2) to seek, through negotiation or otherwise, the revocation or revision of any intellectual property or competition law or policy of a sub-Saharan African country that is designed to promote access to pharmaceuticals or other medical technologies, if such law or policy complies with the Agreement on Trade-Related Aspects of Intellectual Property Rights.
What's happening now
Referred to the Subcommittee on Africa.
Committees of jurisdiction
3